These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8513112)

  • 1. Testing for the existence of a desirable dose combination.
    Hung HM; Chi GY; Lipicky RJ
    Biometrics; 1993 Mar; 49(1):85-94. PubMed ID: 8513112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closure procedures for monotone bi-factorial dose-response designs.
    Hellmich M; Lehmacher W
    Biometrics; 2005 Mar; 61(1):269-76. PubMed ID: 15737103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global tests for combination drug studies in factorial trials.
    Hung HM
    Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resampling in multiple-dose factorial designs.
    Frommolt P; Hellmich M
    Biom J; 2009 Dec; 51(6):915-31. PubMed ID: 20029896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large sample tests for binary outcomes in fixed-dose combination drug studies.
    Wang SJ; Hung HM
    Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size adaptation in fixed-dose combination drug trial.
    James Hung HM; Wang SJ
    J Biopharm Stat; 2012; 22(4):679-86. PubMed ID: 22651108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of multistage testing times and critical values in clinical trials.
    Brittain EH; Bailey KR
    Biometrics; 1993 Sep; 49(3):763-72. PubMed ID: 8241372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of several testing strategies for combination drug efficacy trials based on the closure principle.
    Soulakova JN
    Stat Med; 2009 Jan; 28(2):260-73. PubMed ID: 18991315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mixture gatekeeping procedure based on the Hommel test for clinical trial applications.
    Brechenmacher T; Xu J; Dmitrienko A; Tamhane AC
    J Biopharm Stat; 2011 Jul; 21(4):748-67. PubMed ID: 21516567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing whether an identified treatment is best.
    Laska EM; Meisner MJ
    Biometrics; 1989 Dec; 45(4):1139-51. PubMed ID: 2611321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient and exact approach for detecting trends with binary endpoints.
    Shan G; Ma C; Hutson AD; Wilding GE
    Stat Med; 2012 Jan; 31(2):155-64. PubMed ID: 22162106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian design and analysis of two x two factorial clinical trials.
    Simon R; Freedman LS
    Biometrics; 1997 Jun; 53(2):456-64. PubMed ID: 9192445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority inferences on individual endpoints following noninferiority testing in clinical trials.
    Logan BR; Tamhane AC
    Biom J; 2008 Oct; 50(5):693-703. PubMed ID: 18932132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A group sequential procedure for all-pairwise comparisons of k treatments based on the range statistic.
    Liu W
    Biometrics; 1995 Sep; 51(3):946-55. PubMed ID: 7548710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A note on one-sided tests with multiple endpoints.
    Perlman MD; Wu L
    Biometrics; 2004 Mar; 60(1):276-9; discussion 279-80. PubMed ID: 15032799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new partition testing strategy for multiple endpoints.
    Wang B; Cui X
    Stat Med; 2012 Sep; 31(20):2151-68. PubMed ID: 22532094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple imputation for early stopping of a complex clinical trial.
    Betensky RA
    Biometrics; 1998 Mar; 54(1):229-42. PubMed ID: 9544518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.